Home Health Index | 2019 OCTOBER UPDATE

Amedisys Bounces Back While Other Home Health Stocks Dip in September

Amedisys Bounces Back While Other Home Health Stocks Dip in September

The Stoneridge Partners Home Health Index (HHI) for September shows Amedisys, Inc. (Nasdaq: AMED) made up some of the ground it lost in August, despite a continued downward trend in the greater home health market.

Stoneridge Partners bases its monthly HHI on the stock values of Baton Rouge, Louisiana-based Amedisys and Lafayette, Louisiana-based LHC Group, two of the largest publicly-traded home health companies in the country. The M&A firm also tracks the performance of Addus HomeCare Corporation (Nasdaq: ADUS) stocks, but does not include the Frisco, Texas-based company in its final HHI calculations.

While Amedisys stock was up just more than 2%, LHC Group stock was down nearly 3.6% – leading to slight overall dip of almost 0.6% for home health stocks in September. But that figure also excludes a nearly 10% decline for Addus stock in September, giving back its impressive August gains and then some. In comparison, the S&P 500 rose in September, up nearly 2% from the prior month.

With a bevy of big news coming from Amedisys in the past several weeks, the success of its stock price isn’t surprising. The company announced a new agreement in July with ClearCare to develop a nationwide network of personal care partners, making it an attractive partnership target for Medicare Advantage plans. Then last month, news broke that Amedisys had entered a new partnership with Walmart to expand home health care access nationwide.

Some turmoil within the home health industry as 2020 approaches is also to be expected, according to Stoneridge Partners President Rich Tinsley.

“We’re inching closer to the Patient-Driven Groupings Model, which is making a lot of people nervous,” Tinsley said. “Even these big providers are going to be affected by it because PDGM is the biggest reimbursement shift the industry has seen in decades — and it could come with an 8% payment cut.”

Still, despite the uncertainty of a new payment model, home health stocks were up year-over-year and year-to-date in September. Stocks values tracked by the HHI have increased almost 9% compared to September 2018, and almost 17% since the start of this year. Additionally, Addus was up more than 14% year-over-year and almost 16.5% year-to-date in September.

Quote Of The Month

“One of the ways that digital solutions for behavioral health issues can reduce stigma is that it can be experienced in complete privacy, and it can make treatment for behavioral and emotional health issues much more accessible,” – Ellen Beckjord, associate vice president of population health and clinical affairs at UPMC Health Plan.

Read the Full Article Here:  The future of health care: How digital behavioral health interventions can support your workforce


See It To Believe It!

The Stoneridge Partners Home Health Index (HH Index) is updated monthly and measures the performance of these two publicly traded home health companies, all listed on the NASDAQ:

  • LHC Group (LHCG)
  • Amedisys (AMED)

This graph compares the percentage of the Home Health Index to the percentage change in the S&P 500 Index going back to 2002.

This is a 12 month trailing chart of the HH Index compared to the actual prices of the individual companies that make up the chart.

This graph displays HH Index performance since 2002.

This graph compares the HH Index to the price of Addus stock (non-Medicare).

(Home Health Index October 2019 | Stoneridge Partners)


Here are the results of the stock prices for the past two years:

Company 9/30/19 1 mos change YTD change 9/30/18 9/30/17
Amedisys 131.36 +2.06% +12.43% 123.61 55.96
LHC Group 114.28 -3.56% +22.30% 101.98 70.92
HH Index* 122.82 -0.64% +16.82% 112.80 60.19
S&P 2983.69 +1.96% +19.57% 2924.87 2519.36
Addus 79.19 -9.99% +16.35% 69.29 35.3

Although we track the performance of Addus, they are not included in our HH Index because very little of their revenue comes from Medicare.


Enterprise Value (EV)

EV (in M) 9/30/19 9/30/18 9/30/17
Amedisys 4390 3990 1928
LHC Group 3980 3520 1402
HH Index Total 8370 7510 4226
Addus 1070 857 438

Enterprise Value (EV), aka Selling Price, as Percent of Revenue

Company 9/30/19 9/30/18 9/30/17
Amedisys 242% 252% 131%
LHC Group 195% 260% 144%
HH Index Average* 219% 256% 133%
Addus 188% 188% 106%

Multiples of EV/EBITDA

Think of this as selling price as a multiple of EBITDA.

Company 9/30/19 9/30/18 9/30/17
Amedisys 24.41 26.45 22.77
LHC Group 19.57 34.08 15.18
HH Index Average* 21.99 30.27 20.05
Addus 25.72 23.75 13.44

The above calculations are based on selling price being defined as Enterprise Value (EV), with data provided by Capital IQ. Enterprise value is defined as market cap plus debt, minority interest and preferred shares, minus total cash and cash equivalents. EBITDA is calculated using methodology which may differ from that used by a company for its reporting. (Home Health Index October 2019 | Stoneridge Partners)

Recent Transactions From Around The Country

  • TEAM Services, which is backed by Alpine Investors, has acquired AmeriBest Home Care, a portfolio company of Boyne Capital
  • Appriss Health, provider of the most comprehensive platform for opioid stewardship and substance use disorder (SUD) in the U.S. acquired OpenBeds
  • Arosa+LivHOME acquired LifeLinks, a provider of Aging Life Care services in North Carolina and Tennessee
  • Three Oaks Hospice acquired Total Hospice & Palliative Care, ABS Palliative and Hospice Care and Fellowship Hospice
  • Community Psychiatry Management, the largest outpatient mental health organization in California acquired Calabasas Behavioral Health and Gelbart and Associates

CLOSED by Stoneridge

  • Stoneridge Partners represented an Oklahoma based agency that closed October 2019
  • Stoneridge Partners represented an Illinois based agency that closed September 2019

Exclusively Listed For Sale By Stoneridge Partners

Agency Profile
Reference Number
California$11 million multi-location addiction treatment center. Located in Southern California. 21% bottom line. Strong growth trends. JCAHO-accredited. Available
CaliforniaMedicare-certified home health agency established in 2003. $2 million annual revenue in 2018. PDGM revenue-neutral. Located in Southern California. Clean business with no ADRs. Available
FloridaMedicare-certified home health agency. Approximately $3.8 million in revenue with 17% bottom line. Located in Districts 9 and 10. Revenues split evenly between districts. Accredited. 4.5-star quality of patient care rating.Available
GeorgiaID/DD service provider with $1 million in revenue. Residential and day services offered, located in Atlanta suburb. Available
Illinois$5.5 million accredited Medicare agency located in northeastern Illinois. Strong bottom line. 4.5-star rating by CMS.Available

LouisianaBoutique full-service clinical laboratory specializing in preventative diagnostic testing. Medicare- and Medicaid- certified, with insurance contracts in more than 20 southeastern states. Available
MassachusettsMedicare- and Medicaid-certified home health agency.
$13+ million in annual revenue with continued growth. Diverse payor mix. Strong management in place. Accredited.
MichiganMedicare home health and hospice agency. $10 million in annual revenue with numerous referral relationships. Available
Michigan$2 million ID/DD agency in the Detroit area. Profitable service provider with existing management team in place. Available
Mid-Atlantic$10+ million non-skilled home care agency. Primarily Medicaid reimbursed with 20% EBITDA margins. Strong management team in place. Available
NevadaMedicare-certified home health agency in Las Vegas area. Approximately $1 million in annual revenue. Accredited. Available
New Mexico$2.5 million New Mexico home health agency. 87% Medicare. Long history in the community and existing staff in place.Available
North Carolina$1 million ID/DD agency with real estate. Long-term client base, additional growth potential and strong margins. Available
OklahomaMedicare-certified home health agency with $9.6 million in annual revenue. 98% traditional Medicare and other PPS payors. Medicare- and Medicaid-certified with multiple locations. Available
Oklahoma$5+ million home health, home care, case management, and hospice company. Approximately 15% revenue from hospice, other service line revenues distributed relatively evenly. Multiple locations. Diverse payor sources. Hospice accreditation. Projected PDGM impact of 30%+ for home health. Available
SouthTreatment center with 28 beds, intensive outpatient program capacity of 40, full continuum of substance use disorder services and dual diagnosis treatment capability. JCAHO accreditation pending. $4+ million in revenue, highly competitive in-network contracts. Average census of 30. Existing relationships with county, parole, local hospitals, churches and universities. Solid business in desirable location with little area competition.Available
SouthFull continuum, JCAHO-accredited substance use disorder treatment center on 100+ acre horse ranch. Dual diagnosis treatment capability with 16 beds and 22 staff. $1.5 million EBITDA on $3.5 million in revenue. In-network with great contracts/rates and strong census. Available
SouthPartial hospitalization treatment program/intensive outpatient program seeking strategic partner. Strong census and revenue growth. No direct competition for niche market. Available
Southwest$5+ million 37-bed outpatient treatment center. Fully accredited and recently revamped to increase growth and margin. Great census, UR, acquisition and solid numbers. Out of network but transitioning to some in-network.Available
Southwest64 bed full continuum 64-bed full continuum treatment center in two southwestern US metropolitan cities. JCAHO-accredited and in-network. $4 million pro forma EBITDA run rate based on 30% occupancy with significant growth expected. Strong infrastructure to support growth trajectory.Available
South-AtlanticHome health agency and adult day care center with $12+ million in annual revenue. Home health represents 85% of revenue while adult day represents 15% of revenue. Home health is primarily a Medicaid business but is Medicare-certified. Accredited. Available
South TexasHospice with $3.5 million in annual revenue. Accredited. No cap or regulatory issues. Available
South TennesseeVery rare opportunity in a CON state. Located in Davidson County in Nashville, TN. Projected 2019 revenue in excess of $800,000.Available
Texas$5.3 million Medicaid agency in San Antonio, TX. 16.5% EBITDA. CHAP-accredited. Staff can remain in place for a smooth transition. Available
TexasHome health and hospice covering 10 counties in west Texas/eastern New Mexico with $5 million in revenue. No clinical issues, under CAP. Very profitable. Easily separated. Available
Texas$3.5 million all-Medicaid home care company located in Houston, TX. 20%+ year-over-year revenue growth since 2016. Available
TexasHome health agency located in Arlington, TX with $2.3 million in revenue. Growing and profitable company. Managed staff in place. No compliance issues. Available
Texas$1.7 million Medicare home health agency located in Southwest Houston. Well-established with predictable referral sources and revenues. Available
Texas$1 million Medicare-certified agency licensed in seven counties in the Houston area. 80% traditional Medicare. Available
USANew software application helping build social connections among patients in recovery and giving them increased access to therapists. Potential investment opportunity. Facilitates total successful recovery and gathers important helpful data.Available
Virginia$6 million Medicare-certified agency in Northern Virginia. Available
VirginiaPhysical therapy and wellness operation with $2.3 million in revenue. 95% cash payors. Potential to franchise nationwide. 2018 EBITDA was $257,000. Available
WestPremier provider of primary mental health services for adolescents aged 13-18 with two locations. Currently growing in-network contracts. Available
ColoradoOpportunity to establish Medicare home health agency. Denver market. ACHC accreditation until 2022.Under Contract
Florida$9.5 million home health agency with strong management, clinical and financial operations. 99% of revenue comes from traditional Medicare. Under Contract
FloridaSouth Florida staffing agency. $2 million + revenue. Approximately 30% gross margin. Licensed to service entire state of Florida. Systems and staff in place. Under Contract
KentuckyMedication-assisted treatment center. Suboxone only. Strategic location between Louisville and Lexington, Kentucky. Great reputation with strong clinical team in place. 110 clients with room to grow. In-network contracts. Clients pay $150 per visit for counseling twice per month. Owners are near retirement and will help with the transition. Under Contract
Michigan$1.5 million private duty home health agency in eastern Michigan. Profitable and well-positioned for additional growth. Self-sufficient staff in place. 82 long-term clients. Under Contract
Mid-west$5 million Midwest-based ABA provider. Day supports and counseling. Highly profitable and respected. CARF accredited. Contracted with state and insurance companies. Under Contract
Multi-StateWell-established pediatric provider. Revenue more than $40 million. Medicaid and insurance accepted. Under Contract
New MexicoHome health and hospice with $15 million in annual revenue. Revenue split is 2/3 home health and 1/3 hospice. Medicare- and Medicaid-certified. Accredited. Under Contract
New YorkLicensed home care services agency with services in five boroughs. Approximately $20 million in revenue and a long-standing history in the community. Under Contract
North Carolina$5 million Medicaid agency. $5 million Medicaid agency. CAP/PCS services. Long history of providing quality services. Under Contract
Pacific NorthwestFull continuum substance use disorder, mental health and gambling addiction treatment center in Washington state with $3,625,000 in revenue and $1,100,000 EBITDA. 40 bed facility with 40 employees. Strong census, full outpatient program and Medicaid payors. Under Contract
SouthwestProvider of waiver and intermediate care facility ID/DD services with $25 million in annual revenue. Statewide platform with a strong management team and excellent reputation for quality services. Under Contract
TexasThree Hospice companies with Three hospice companies with affiliated home health and $6 million in total revenue. Locations in south, southcentral, and southeast Texas. Under Contract
Texas$4.2 million home health agency. 17.5% bottom line. Located in Houston, TX. Large coverage area. Diverse referral network. Fully staffed with no clinical issues. Under Contract
Texas$3.5 million Medicare certified $3.5 million Medicare certified home health agency located in San Antonio, TX. Fully staffed and CHAP-accredited. Branch office is included in sale.Under Contract

Do you know of any acquisitions that have taken place?  We are interested in your comments.  At the top of this column is a “Contact Tab” with a section for comments.  These can be sent anonymously and the return email address can be left blank.


Another Cartoon Favorite 




Home Health Index October 2019 | Stoneridge Partners

From Rich Tinsley, Publisher of “Home Health Index”. Rich can be reached at rich@stoneridgepartners.com or (239) 561-0826 and toll-free 800-218-3944

Previous editions of this monthly newsletter can be searched for at the bottom of the home page of the Home Health Index. Links to Google Finance: Amedisys | LHC Group

Please follow us on Facebook  and Linkedin